康柏西普联合激光治疗急进性早产儿视网膜病变

目的 观察康柏西普、激光单独及联合治疗急进性早产儿视网膜病变(ROP)的临床效果。 方法 采用等距随机抽样法将2016年2月至2017年12月收治的63例(126眼)ROP患儿随机分为激光治疗组、康柏西普治疗组、康柏西普联合激光治疗组,每组21例(42眼)。对比3组临床疗效,观察视网膜电流图相关分析指标及等效球镜度、散光度数变化,并分析治疗期间并发症发生情况及随访结果。 结果 激光治疗组、康柏西普治疗组、康柏西普联合激光治疗组患者疾病控制率分别为71.43%、66.67%、95.24%(H=5.694, P=0.058)。在闪光视网膜电图(F-ERG)反应振幅上,视杆反应b波、最大混合反应a、b波,3组比较差异均有统计学意义(P均<0.05)。在F-ERG反应潜伏期,视锥反应a、b波,3组比较差异均有统计学意义(P均<0.05)。3组患者近视、高度近视、散光、高度散光发生率比较,差异均有统计学意义(P均<0.05)。激光治疗组、康柏西普治疗组、康柏西普联合激光治疗组患者并发症发生率分别为23.80%、19.04%、14.28%(χ2=0.618, P=0.432)。随访期间,激光治疗组、康柏西普治疗组、康柏西普联合激光治疗组患者ROP复发率为33.33%、28.57%、4.76%,激光治疗组、康柏西普治疗组ROP复发率均高于康柏西普联合激光治疗组(P均<0.05)。 结论 康柏西普联合激光治疗ROP临床疗效较好,安全性较高。

Clinical study of compaq combined with laser in the treatment of retinopathy of prematurity

Objective To observe the clinical effect of treatment with Compaq, laser, and a combination for the treatment of retinopathy of prematurity(ROP). Methods Sixty-three children(126 eyes)with ROP treated in our hospital from February 2016 to December 2017 were randomly divided into three groups of 21 patients(42 eyes)using the envelope method. Laser photocoagulation treatment group was treated with laser photocoagulation alone, compaq treatment group was treated with compaitcept glass cavity injection alone, and combined treatment group was treated with compaitcept glass body cavity injection and laser irradiation combined with laser photocoagulation. The clinical effects observed in the three groups were compared, and the indices related to the retinal electroretinogram and changes in the equivalent spherical mirror and astigmatism were analyzed. Complications and follow-up results were analyzed during and after treatment. Results The rate of controlled disease in laser photocoagulation treatment group, compaq treatment group and combined treatment group was 71.43%, 66.67% and 95.24%(H=5.694, P=0.058). Regarding the amplitude of the flash electroretinogram(F-ERG)reaction, the amplitude of the b-wave, the cone-rod mixed maximum response a- and b-waves, there was significant difference between the above three groups(all P<0.05). Regarding the F-ERG response latency, peak mixed rod-cone response a- and b-wave, there was significant difference between the above three groups(all P<0.05). Regarding myopia, high myopia, astigmatism, and high astigmatism, there was significant difference between the above three groups(all P<0.05). The incidence of complications was 23.80%, 19.04% and 14.28%(χ2=0.618, P=0.432)in laser photocoagulation treatment group, compaq treatment group and combined treatment group. During the follow-up period, the recurrence rate of ROP in laser photocoagulation treatment group, compaq treatment group and combined treatment group was 33.33%、28.57% and 4.76%. The recurrence rate of ROP in laser photocoagulation treatment group and compaq treatment group significantly higher than that in combined treatment group(all P<0.05). Conclusion Treatment with Compaq combined with laser is effective and safe for the treatment of ROP.